Introduction {#S1}
============

Type III interferons (IFN-λ) are members of the interferon (IFN) family and critical mediators of antiviral defenses^[@R1],\ [@R2],\ [@R3]^. IFN-λ family members have functions similar to type I IFN, and are structurally related to the IL-10 cytokine family, utilizing the IL-10 receptor as a part of their heterodimeric receptor with IFN-λR1 chain^[@R4]^. Although IFN-λ has overlapping functions with type I IFNs, several studies have revealed a unique, non-redundant role for IFN-λ in mediating protection against disease and pathology in the liver and at mucosal and barrier surfaces^[@R5],\ [@R6],\ [@R7],\ [@R8],\ [@R9],\ [@R10]^.

Influenza A virus (IAV) is a respiratory pathogen that causes seasonal epidemics and also presents the potential for major pandemic outbreaks and global disease through continual emergence and re-emergence from avian reservoirs. The high incidence of IAV infection, coupled with low vaccine effectiveness during the 2017--2018 season, highlights the necessity to gain a better understanding of the processes that regulate the immune responses against infection to guide efforts aimed at developing effective therapeutic and vaccine adjuvants to protect against infection^[@R11]^.

As an innate immune and immune-regulatory cytokine, IFN-λ has the capacity to direct protective immunity against IAV infection. When administered intransally following IAV challenge, IFN-λ restricts IAV infection without inducing excessive, tissue damaging inflammation typically associated with type I IFN administration^[@R12],\ [@R13],\ [@R14],\ [@R15]^. The protective and non-injurious effect of IFN-λ are attributed in part to the selective expression of IFN-λR1 compared to the broad expression of the type I IFN receptor (IFNAR), wherein IFN-λR1 is selectively expressed on epithelial cells, neutrophils, plasmacytoid dendritic cells and potentially natural killer (NK) cells that contribute to IAV immunity^[@R12],\ [@R13],\ [@R16],\ [@R17],\ [@R18],\ [@R19],\ [@R20]^.

Although IFN-λ directs innate immune defenses that can restrict IAV infection, the contribution of IFN-λ signaling to adaptive immunity is less clear^[@R21],\ [@R22],\ [@R23]^. IFN-λ has been shown to enhance T~H~1 T cell responses in the lung, suggesting it has a role in regulating immune polarization during IAV infection^[@R21],\ [@R22]^. Despite these observations, the direct function of IFN-λ on programming and maintenance of adaptive immune responses during IAV infection remains largely unknown. Here, we utilized murine infection models to investigate the role of IFN-λ (of which IFN-λ2 and IFN-λ3 are conserved between mice and humans) in adaptive immunity against IAV. We demonstrate that IFN-λ signaling is critical for the development of virus-specific CD8^+^ T cells and generation of protective immunity that is able to provide cross-protection against heterosubtypic IAV re-challenge. We found that the blunted CD8^+^ T cell response in IFN-λ-deficient (*Ifnlr1*^*--/--*^) mice is due to a defect in the activation, migration, and function of dendritic cells (DCs) linked with aberrant expression of a DC-derived IL-10 immunoregulatory gene network. IFN-λ specifically programs migratory, antigen presenting CD103^+^ DCs to mediate CD8^+^ T cell activation for broad protection against IAV infection, and for heterosubtypic virus challenge that underscores contemporary IAV outbreaks in humans. Thus, IFNλ, through the recruitment and function of CD103^+^ DCs and regulation of IL-10 production, is an essential component of effective immunity against IAV infection and for cross-protection against heterosubtypic IAV emergence.

Results {#S2}
=======

IFN-λ signaling is required to generate protective memory T cell responses {#S3}
--------------------------------------------------------------------------

To assess the role of IFN-λ signaling downstream of IFN-λR1 in controlling protection against secondary IAV infection we examined the response to heterosubtypic IAV challenge and determined the ability of *Ifnlr1*^*--/--*^ mice to mount a protective homosubtypic and heterosubtypic (T cell-dependent) memory response against IAV infection. We interrogated both homo- and hetero-subtypic re-challenge as neutralizing antibody responses have been demonstrated to effectively prevent homosubtypic IAV infection, but heterosubtypic IAV infection is a common occurrence in humans and other susceptible species during pandemic and seasonal outbreaks caused by exposure to related heterosubtypic IAV strains. It has been established in mouse models of heterosubtypic IAV re-challenge, as well as during human infection, that neutralizing antibody responses are not effective at preventing heterosubtypic IAV infection and disease^[@R24],\ [@R25],\ [@R26]^. In contrast, CD8^+^ T cells are critical mediators of protection against heterosubtypic IAV infection while antibodies are dispensible^[@R24],\ [@R27],\ [@R28],\ [@R29]^. As in previous heterosubtypic IAV challenge studies of mice, we mock-infected animals, challenged them with a low dose of murine-adapted IAV A/PR/8/34 (IAV-PR8) that leads to clinical respiratory illness and weight loss with complete survival and recovery^[@R30],\ [@R31]^, or challenged with an equivalent infectious dose of recombinant H3N2 IAV containing the HA and NA of A/HK/1/68 and the remaining segments from IAV-PR8 (IAV-X31). The dose of IAV-PR8 utilized consistently lead to a minor, yet statistically significant increase in virus titers, and caused similar weight loss and respiratory illness, but no lethality in wildtype and *Ifnlr1*^*--/--*^ mice as described by others^[@R13],\ [@R15],\ [@R32]^ ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). On day 45 following initial infection, all mice were challenged with a completely lethal dose of 2000 PFU IAV-PR8 ([Fig. 1a](#F1){ref-type="fig"}), thus modeling IAV cross-exposure as occurs during seasonal epidemics. Both wildtype and *Ifnlr1*^*--/--*^ mice succumbed to secondary infection following mock primary infection while prior exposure to IAV-PR8 provided immune memory that protected against disease ([Figure 1b](#F1){ref-type="fig"}--[d](#F1){ref-type="fig"}). Antibodies likely contribute to this protection against the homologous 2000 PFU challenge as we observed similar levels of IAV-specific IgM, IgG, IgG1, and IgG2a antibodies in bronchiole alveolar lavage fluid of wildtype and *Ifnlr1*^*--/--*^ mice, and a significant increase in IgA in *Ifnlr1*^*--/--*^, on day 35 following sublethal IAV-PR8 infection ([Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). Prior infection with IAV-X31 resulted in weight loss and illness but no change in overall susceptibility to IAV-PR8 heterosubtypic infection in wildtype mice ([Figure 1b](#F1){ref-type="fig"}--[d](#F1){ref-type="fig"}). Importantly, *Ifnlr1*^*--/--*^ mice previously infected with IAV-X31 were increasingly susceptible to IAV-PR8 heterosubtypic infection and exhibited a significant reduction in survival concomitant with accelerated and prolonged weight loss and disease symptoms, with a significant increase in illness score in *Ifnlr*^*--/--*^ mice on days 2--5 post heterosubtypic IAV challenge compared to wildtype ([Figure 1b](#F1){ref-type="fig"}--[d](#F1){ref-type="fig"}). These results indicate that IFN-λ signaling is critical in generating T cell-mediated cross-protective immunity against heterologous IAV infection.

To determine whether populations of IAV-specific T cells were functionally altered in *Ifnlr1*^--/--^ mice compared to wildtype at a memory time point (day 35 post infection) following IAV infection, we challenged wildtype and *Ifnlr1*^*--/--*^ mice with IAV-PR8 and assessed T cell responses in lung-draining mediastinal lymph nodes (dLN) on day 35 post infection. We observed a significant reduction in the frequency and numbers of IAV-specific CD4^+^ and CD8^+^ T cells in dLN of *Ifnlr1*^*--/--*^ mice compared to wildtype on day 35 post infection ([Figure 2a](#F2){ref-type="fig"} and [2b](#F2){ref-type="fig"}). These results suggest that insufficient memory T cells likely account for the enhanced susceptibility of *Ifnlr1*^--/--^ mice upon heterosubtypic virus secondary challenge.

IFN-λ signaling is essential for the development of the IAV-specific CD8^+^ T cell response {#S4}
-------------------------------------------------------------------------------------------

To determine the role of IFN-λ signaling in programming the effector T cell response against IAV infection, we measured the IAV-specific CD8^+^ T cell response in the lungs of wildtype and *Ifnlr1*^*--/--*^ mice following IAV infection. On day 9 post infection, the frequency and numbers of CD8^+^ T cells specific to the IAV immunodominant NP~366~-epitope were significantly reduced in *Ifnlr1*^*--/--*^ animals compared to wildtype ([Figure 3a](#F3){ref-type="fig"}). Additionally, the lung CD8^+^ T cells displayed reduced amounts of IFN-γ and TNF production in *Ifnlr1*^*--/--*^ compared to wildtype mice during IAV infection ([Figure 3b](#F3){ref-type="fig"}--[d](#F3){ref-type="fig"}). A similar, significant reduction in the PA~224~-specific response of *Ifnlr1*^--/--^ mice infected with IAV was also observed (data not shown). In contrast, no difference in the frequency or numbers of IAV-specific CD4^+^ T cells or their cytokine production following stimulation with NP~311~ IAV peptide *ex vivo* was found between wildtype and *Ifnlr1*^*--/--*^ mice on day 9 post infection ([Supplementary Figure 3](#SD1){ref-type="supplementary-material"}). Together, these findings identify a requirement for IFN-λ signaling in the generation of an optimal IAV-specific CD8^+^ T cell response.

IFN-λ signaling in DCs is important for function and priming of IAV-specific CD8^+^ T cells {#S5}
-------------------------------------------------------------------------------------------

Previous studies have shown that T cells lack IFN-λ receptor expression and do not respond directly to IFN-λ^[@R23]^. However, given the defect in the IAV-specific CD8^+^ T cell response in *Ifnlr1*^*--/--*^ mice, we opted to assess whether IFN-λ signaling, intrinsic or extrinsic to CD8^+^ T cells, was responsible for the aberrant CD8^+^ T cell response in the *Ifnlr1*^*--/--*^ mice. Stimulation of lung homogenates with phorbol 12-myristate 13-acetate (PMA) and ionomycin yielded equivalent amounts of IFN-γ and TNF produced by wildtype and *Ifnlr1*^*--/--*^ CD8^+^ T cells ([Figure 3b](#F3){ref-type="fig"}--[d](#F3){ref-type="fig"}), suggesting that CD8^+^ T cells are fully capable of producing these cytokines in the absence of *Ifnlr1* and IFN-λ signaling. Further, we purified CD8^+^ T cells from the spleens of wildtype and *Ifnlr1*^*--/--*^ mice and stimulated them with plate bound α-CD3/CD28. Both wildtype and *Ifnlr1*^*--/--*^ CD8^+^ T cells underwent robust cell division and expressed the activation markers CD44 and CD69 when stimulated *ex vivo* ([Figure 4a](#F4){ref-type="fig"}). Thus, the defect in the activation of the IAV-specific CD8^+^ T cell response in *Ifnlr1*^*--/--*^ is not T cell-intrinsic.

To verify that the defect in the IAV-specific CD8^+^ T cell response was due to a T cell-extrinsic effect that impacts T cell activation and functional differentiation, we transferred wildtype, CFSE-labeled, GP~33~-specific CD8^+^ T cells expressing a disparate CD45 molecule into wildtype and *Ifnlr1*^*--/--*^ mice, and infected the mice with IAV-PR8 containing a GP~33~ epitope. After 3.5 days in *Ifnlr1*^*--/--*^ hosts, the average number of divisions activated GP~33~-specific CD8^+^ T cells had undergone was significantly reduced in dLN compared to GP~33~-specific CD8^+^ T cells transferred to WT mice ([Figure 4b](#F4){ref-type="fig"}). Together, these results demonstrate that the defect in the CD8^+^ T cell response against IAV occurs early at the time of antigen priming and is caused by a T cell-extrinsic process in *Ifnlr1*^*--/--*^ mice.

IFN-λ signaling in DCs is required for their function and migration to dLN following IAV infection {#S6}
--------------------------------------------------------------------------------------------------

To determine if a defect in DC function could be responsible for the aberrant CD8^+^ T cell response in *Ifnlr1*^*--/--*^ mice, we evaluated the responses of wildtype and *Ifnlr1*^*--/--*^ bone marrow-derived DCs (BMDCs) to several stimuli. We found that BMDCs expressed *Ifnlr1* mRNA with increasing levels upon IAV infection in contrast to their levels of *Ifnar1* expression, which was similar in both wildtype and *Ifnlr1*^--/--^ BMDCs irrespective of infection ([Figure 4c](#F4){ref-type="fig"}). Stimulation of BMDCs with 500 ng IFN-λ3 or 10 ng IFNα2 lead to similar phosphorylation of the transcription factor STAT1, which is downstream of IFN-λR1 ([Supplementary Figure 4a](#SD1){ref-type="supplementary-material"}), and responded to IFN-λ in a dose-dependent manner ([Supplementary Figure 4b](#SD1){ref-type="supplementary-material"}), indicating that BMDCs respond directly to IFN-λ stimulation. Further, these BMDCs expressed interferon stimulated genes (ISGs) 12 hrs following treatment with IFN-λ3 ([Supplemental Figure 4c](#SD1){ref-type="supplementary-material"}). However, we found that *Ifnlr1*^*--/--*^ BMDCs were unable to increase CD40 surface protein expression following IAV infection ([Figure 4d](#F4){ref-type="fig"}). These changes in activation upon infection were not due to changes in viral burden in BMDCs, as wildtype and *Ifnlr1*^--/--^ BMDCs expressed similar levels of IAV NP at this time following infection ([Figure 4e](#F4){ref-type="fig"}). Further, *Ifnlr1*^*--/--*^ BMDCs ability to uptake and process antigen as measured by DQ ovalbumin (DQ-Ova) fluorescence was reduced compared to wildtype BMDCs ([Figure 4f](#F4){ref-type="fig"}). Thus, IFN-λ signaling is intact in BMDCs, and is essential for DC maturation and function following IAV infection.

To determine if DC responses were defective *in vivo* in *Ifnlr1*^*--/--*^ mice, we assessed the ability of DCs to migrate from the lungs to dLN. 5(6)-Carboxyfluorescein N-hydroxysuccinimidyl ester (CFSE) was administered intranasally to the lungs of wildtype and *Ifnlr1*^*--/--*^ mice to label resident cells^[@R33]^. Migration of antigen presenting cells (APCs) from the lungs to dLN following IAV-PR8 infection was monitored by measuring the accumulation of CFSE^+^ CD11c^+^ cells in the lung dLN ([Figures 5a](#F5){ref-type="fig"}--[5c](#F5){ref-type="fig"}). Although pulmonary APCs accumulated in dLN of WT mice 24 hrs following IAV infection, the migration of APCs to the lung dLN in *Ifnlr1*^*--/--*^ mice was significantly reduced ([Figures 5b](#F5){ref-type="fig"} & [5c](#F5){ref-type="fig"}). We further assessed the lung to dLN migration of specific DC subsets including inflammatory DCs (iDC), bulk conventional DCs (cDCs), CD4^+^ DCs, cross-presenting CD8α^+^ DCs and CD103^+^ DCs, noting that the latter have been shown to take up antigen in the lung and migrate to dLN to effectively cross-present antigen for activation of CD8^+^ T cells^[@R34],\ [@R35]^. There was no difference in iDC migration between wildtype and *Ifnlr1*^*--/--*^ mice but we did observe a significant reduction in accumulation of cDCs in *Ifnlr1*^*--/--*^ compared to WT ([Figure 5e](#F5){ref-type="fig"}). We found a significant reduction in migratory CD103^+^ DCs and cross-presenting CD8α^+^ DCs in dLN of *Ifnlr1*^*--/--*^ mice following IAV infection ([Figure 5f](#F5){ref-type="fig"} & [5g](#F5){ref-type="fig"}). These findings show that IFN-λ signaling is required for DC function and specific DC subset migration to the dLN following IAV infection.

To determine if CD103^+^ DC and CD8α^+^ DC subsets were functionally and differentially dependent on IFN-λ or type I IFN signaling, we assessed the protein and mRNA level of type I IFN receptor expression of each DC subset. In particular, CD103^+^ DCs have been described to be resistant to type I IFN signaling^[@R36]^, and therefore postulated that CD103^+^ DC and CD8α^+^ DC subsets might be dependent on IFN-λ signaling for their maturation, migration, and antigen presentation functions. Compared to iDCs that are known to respond to type I IFN, IFNAR1 protein levels were reduced on the surface of CD8α^+^ DCs and CD103^+^ DCs found in dLN 3 days following IAV-PR8 infection ([Figure 5h](#F5){ref-type="fig"}). We note that a reliable antibody or an immunoassay to detect IFN-λR1 on the surface of cells is not currently available; therefore we utilized RT-qPCR analysis to measure *Ifnlr1* gene expression. We found that both sorted iDCs and CD103^+^ DCs from the lungs of naive mice express *Ifnar1* mRNA, whereas *Ifnlr1* mRNA expression was detected only in CD103^+^ DCs ([Figure 5i](#F5){ref-type="fig"}). These results were similar to relative *Ifnar1* and *Ifnlr1* mRNA expression from lung CD103^+^ DCs previously defined by microarray analysis and available in the Immunological Genome Project database^[@R37]^. In summary, these data further indicate that IFN-λ signaling induces a central program that directs the migration of lung DCs to accumulate in dLN during acute IAV infection. Thus, IFN-λ might impart a gene expression program in DCs to regulate their function and downstream adaptive immune responses during IAV infection.

IFN-λ signaling is responsible for regulation of an IL-10 immunoregulatory network in DCs {#S7}
-----------------------------------------------------------------------------------------

To define the DC gene expression profile associated with IFNλ signaling and response we conducted RNA sequencing analysis of mRNA from cDCs (CD3^--^/CD19^−^/MHC-II^+^CD11b^--^CD11c^+^) sorted from dLN of wildtype and *Ifnlr1*^--/--^ mice on day 4 following IAV infection. This time point corresponded with DC accumulation from the lung to the dLN to prime the CD8^+^ T cell response. This examination of DCs allowed for identifying differentially expressed (DE) genes within the interface of innate and adaptive immunity that could impart function to program DC actions through response to IFN-λ ([Figure 6a](#F6){ref-type="fig"}). A Venn diagram of significantly induced (upregulated) or suppressed (down-regulated) genes showed overlapping and distinct genes amongst DCs from IAV-infected wildtype and *Ifnlr1*^--/--^ mice compared to mock-infected controls of each genotype ([Figure 6b](#F6){ref-type="fig"}). This indicates there is a global transcriptional program in *Ifnlr1*^*--/--*^ cDCs that is distinct from wildtype cDCs in dLN, demonstrating IFN-λ signaling contributes to the functional programming of the DC responsible for presenting antigen to activate IAV-specific CD8^+^ T cell responses. A scatter plot showing all genes undergoing significant changes in expression for each genotype compared to mock infection (listed in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}) indicated that a large number of genes, including a number of interferon stimulated genes (ISGs), were induced to equivalent levels in wildtype and *Ifnlr1*^*--/--*^ DC upon IAV infection *in vivo* ([Figure 6c](#F6){ref-type="fig"}). This similar upregulation of at least a subset of ISGs suggested that it was not simply a defect in general and canonical interferon signaling that was driving the defect observed in *Ifnlr1*^*--/--*^ animals. Notably, the upper left quadrant of this scatter plot represented a divergent response of genes that were downregulated in wildtype DCs during IAV infection but upregulated in *Ifnlr1*^*--/--*^ DCs. The genes in this quadrant that were highly upregulated in *Ifnlr1*^*--/--*^, but downregulated in wildtype included *Loc101055769, Rgs9bp, Tmem246, Wdr31*, and *Il10*. Analysis of genes involved in DC maturation also identified striking differences in transcriptional profiles in *Ifnlr1*^*--/--*^ compared to wildtype ([Figure 6d](#F6){ref-type="fig"}). For example, *Il10*, which was also identified as a gene whose expression was highly divergent between wildtype and *Ifnlr1*^*--/--*^, was of particular interest as the cytokine actions of IL-10 have been recently described to reduce CD8^+^ T cell antigen sensitivity and function in the context of chronic infection^[@R38]^. Further analyses revealed a non-canonical cell-mediated immune network of genes with IL-10 as a central regulatory hub in *Ifnlr1*^*--/--*^ cDCs from dLN ([Figure 6e](#F6){ref-type="fig"}). Many genes in this network were not induced to statistical significance in wildtype cDCs *in vivo* as indicated by white nodes ([Figure 6e](#F6){ref-type="fig"}). To determine whether the change in *Il10* mRNA translated into a difference at the protein level, we infected wildtype and *Ifnlr1*^*--/--*^ BMDCs with IAV and assessed IL-10 concentration in culture supernatants. Although BMDCs from wildtype mice did not secrete detectable amounts of IL-10, IL-10 production and/or secretion was detected in *Ifnlr1*^*--/--*^ BMDCs following IAV infection ([Figure 6f](#F6){ref-type="fig"}), validating the transcriptional upregulation of *Il10* to program an IL-10 response network in dLN cDCs from *Ifnlr1*^*--/--*^ mice. Overall, these data indicate that during IAV infection the cDCs in dLN undergo gene induction patterns that are dependent on IFN-λ signaling, and that IFN-λ signaling is essential for the negative regulation of IL-10 and its immunoregulatory network that links with aberrant CD8^+^ T cell priming and responses during IAV infection.

IFN-λ signaling in CD11c^+^ cells is required for the generation of pulmonary IAV-specific CD8^+^ T cells {#S8}
---------------------------------------------------------------------------------------------------------

Our observations support a pivotal role for IFN-λ signaling in DCs via regulation of a unique transcriptional profile and gene actions that direct DC function for the proper priming of CD8^+^ T cells against IAV infection. To determine if cDC-specific IFN-λ signaling (including CD8α^+^ DCs and CD103^+^ DCs) was required to impart the IAV-specific CD8^+^ T cell response, we examined the response to IAV infection in conditional knockout mice where IFN-λR1 expression in CD11c^+^ cells is absent (*Ifnlr1*^*fl/fl*^*Itgax-*cre)^[@R39]^. Upon IAV-PR8 infection there was no difference in weight loss between *Ifnlr1*^*fl/fl*^ wildtype controls and *Ifnlr1*^*fl/fl*^*Itgax-*cre, similar to full *Ifnlr1*^*--/--*^ ([Figure 7a](#F7){ref-type="fig"}). Loss of IFN-λR1 specifically in CD11c^+^ cells phenocopied global *Ifnlr1*^*--/--*^ mice, as we found a significant reduction in the IAV-specific CD8^+^ T cell response relative to wildtype controls ([Figure 7b](#F7){ref-type="fig"}). There was no defect in the CD4^+^ T cell response between *Ifnlr1*^*fl/fl*^ wildtype controls and *Ifnlr1*^*fl/fl*^*Itgax-*cre mice, similar to wildtype and *Ifnlr1*^*--/--*^ mice ([Figure 7c](#F7){ref-type="fig"}). In addition to DCs, alveolar macrophages, splenic macrophage subsets, NK cells, and to a much lesser extent a few other immune cell subsets also express CD11c^[@R40]^. To address the potential impact of the deletion of *Ifnlr1* from macrophages that also occurs within the *Ifnlr1*^*fl/fl*^*Itgax-*cre, mice, we utilized *Ifnlr1*^*fl/fl*^*Lyz2-*cre mice specifically lacking *Ifnlr1* in macrophages (and neutrophils), and evaluated the CD8^+^ T cell response to IAV infection. *Ifnlr1*^*fl/fl*^*Lyz2-*cre mice had CD4^+^ and CD8^+^ T cell responses similar to *Ifnlr1*^*fl/fl*^ wildtype controls ([Supplementary Figure 5](#SD1){ref-type="supplementary-material"}). Thus, IFN-λ signaling in DCs but not macrophages serves to direct their actions to program CD8^+^ T cells against IAV infection. Taken together, our study reveals an important requirement for IFN-λ signaling in programming DCs for activation, maturation, and migration from lung to dLN during IAV infection to prime an optimal CD8^+^ T cell response that is required for effective immune memory and protection against heterosubtypic IAV infection ([Supplementary Figure 6](#SD1){ref-type="supplementary-material"}).

Discussion {#S9}
==========

Herein we investigated the role of IFN-λ signaling in programming adaptive immune responses, in particular we examined DC function and CD8^+^ T cell-mediated immunity that is key for clearance of IAV^[@R41]^. Our results highlight the critical function of IFN-λ signaling in DCs at the innate/adaptive immune interface required for activation, function, and maintenance of IAV-specific CD8^+^ T cell responses critical for heterosubtypic IAV protection. Our studies reveal that IFN-λ signaling in DCs is essential for optimal antigen uptake and processing, upregulation of costimulatory molecules, regulation of IL-10 production by DCs, DC migration to dLN, and CD8^+^ T cell activation. Intriguingly, we found that IFN-λ actions are specific to DC subsets (CD8α^+^ DCs and CD103^+^ DCs) important for migration to the dLN and regulation of CD8^+^ T cells *in vivo* during IAV infection. However, multiple DC subsets are capable of priming IAV-specific CD4^+^ T cell responses^[@R42],\ [@R43]^, which likely explains why we observed similar effector CD4^+^ T cell response in the lungs of wildtype and *Ifnlr1*^*--/--*^ mice in the lungs during IAV infection. This outcome suggests a unique requirement of IFN-λ signaling for the optimal migration and function of CD103^+^ DCs to program effective CD8^+^ T cell-mediated protective immunity. Thus our results uncover a unique and non-redundant role for IFNλ signaling in adaptive immunity.

Coupled with publicly available microarray data, our results reveal that CD103^+^ DCs express low level of IFNAR compared to other DC subtypes and are resistant to type I IFN^[@R36],\ [@R37]^. Conversely, lung CD103^+^ DCs express high *Ifnlr1* levels relative to other DC subsets^[@R37]^. Unfortunately, specific and sensitive antibodies required to measure the surface expression of IFN-λR1 are currently unavailable, but our results indicate DCs are able to respond directly to IFN-λ3 (an IFN-λ subtype conserved in both mice and humans). We hypothesize CD103^+^ DCs rely upon IFN-λ signaling for optimal activation due to higher levels of IFN-λ receptor expression and their specific defect in cell migration to dLN during IAV infection *in vivo* in *Ifnlr1*^*--/--*^ compared to other DC subsets. This specific responsiveness of CD103^+^ DC subsets to IFN-λ signaling represents a novel potential target for development of IFNλ-based adjuvants to IAV vaccination.

We identified IL-10 and an *Il10* immunoregulatory gene network containing *Rel* and *Il27* that was specifically in cDCs in *Ifnlr1*^*--/--*^, distinct from canonical IFN signaling, and linked with the defective CD8^+^ T cell response against IAV infection *in vivo*. Rel/NF-kB signaling in DC has been shown to lead to upregulation of IL-27 and subsequently IL-10, which performs an immunoregulatory function in shaping the CD4^+^ T cell repertoire^[@R44]^. Additionally, IL-10 has recently been shown to direct immunosuppressive actions to reduce CD8^+^ T cell activation and function in the context of chronic viral infection^[@R38]^, and IL-10 production from DCs was linked to T cell suppression in response to anti-tumor vaccination^[@R45]^. In the context of IAV infection, we propose a model in which IFN-λ signaling regulates and restricts IL-10 production in antigen cross-presenting CD103^+^ DCs to facilitate optimal activation of CD8^+^ T cell responses that are critical for clearance of infection.

The aberrant/immunosuppressive function of CD103^+^ DCs and reduced CD8^+^ T cell responses in *Ifnlr1*^*--/--*^ mice during IAV infection ultimately culminated in enhanced mortality during heterosubtypic IAV re-challenge. This heterosubtypic IAV challenge model is dependent upon CD8^+^ T cell responses for protection and mimics the mode of protection that can occur in the human population during the emergence of novel, recombined IAV strains, such as the pandemic H1N1 strain in 2009^[@R26],\ [@R46]^. In addition to this natural frequency of occurrence in the human population, the emerging threat of avian influenza IAV highlight the necessity for developing a comprehensive understanding of host factors that favor development of protective immunity. Given the importance of CD103^+^ DCs in delivery of IAV antigen for cross-priming of CD8^+^ T cell responses^[@R30],\ [@R34],\ [@R35]^, and the requirement for IFN-λ to impart DCs function, our results suggest IFN-λ could have application as a immune adjuvant to IAV vaccination. Future studies will focus on revealing the kinetics and requirements for development of CD8^+^ and CD4^+^ T cell memory responses in *Ifnlr1*^*--/--*^ and in the context of activation during vaccination in conjunction with IFN-λ. Although several recent studies have highlighted the potential for IFNλ to impart superior protective immunity over type I IFN against IAV infection^[@R12],\ [@R13],\ [@R14]^, our data reveals that IFN-λ signaling is essential in programming DCs function during IAV infection. In particular, our findings support a model in which IFN-λ signaling functions to limit IL-10 immunosuppressive actions, thus facilitating DCs function for enhanced CD8^+^ T cell protection against heterosubtypic IAV challenge. Overall, our study highlights the important role of IFN-λ signaling to program an innate-adaptive immune interface in which an IFN-λ-DC-CD8^+^ T cell axis elicits protective adaptive immunity against IAV infection and exposure to reemergent, heterosubtypic IAV.

Materials/Methods {#S10}
=================

Specific details are listed below and in the Life Sciences Reporting Summary.

Mice {#S11}
----

WT C57BL/6/J and *Ifnar1*^--/--^ mice were purchased from The Jackson Laboratory or bred in house from breeders obtained from The Jackson Laboratory. *Ifnlr1*^--/--^ mice were kindly provided by Dr. Michael Diamond and maintained as a colony in the Gale Laboratory^[@R47]^. The entire Ifnlr coding sequence is ablated in these mice^[@R48]^. *Ifnlr1*^*fl/fl*^, *Lyz2*-cre, and *Itgax*-cre mice were provided by Dr. Herbert Virgin and maintained in the Gale Laboratory^[@R39]^. Briefly, these conditional-ready *Ifnlr1*^*fl/fl*^ mice contain two loxP sites around Exon 2 of *Ifnlr1*. Upon expression of Cre-recombinase, the excision of this floxed site leads to a change in the amino acid sequence and a premature stop at amino acid 42^[@R39]^. Male and female mice were between the ages of 8 and 10 wks at the onset of experiments. All experiments were performed according to approved IACUC protocols at the University of Washington.

Viruses {#S12}
-------

All viruses were propagated in embryonated chicken eggs as previously described^[@R49]^. X31, PR8, PR8-GP~33~, PR8--2W. PR8 viruses expressing GP33 (lymphocytic choreomeningitis virus) or 2W1S (from *Salmonella typhimurium*) epitopes were engineered into a site within the stalk of NA known to be tolerant to insertions^[@R50]^ and generated as previously described^[@R51]^. The PR8--2W virus was utilized in experiments to evaluate T cell responses as CD4^+^ T cells specific for the 2W1S epitope in C57Bl/6/J mice undergo a large expansion relative to other CD4^+^ T cell specificities^[@R52]^, allowing for easier analysis of CD4^+^ T cell responses specifically activated by IAV infection.

Murine Infections, Tissue Harvest, and Processing {#S13}
-------------------------------------------------

For all primary infection studies, mice were challenged with 40 PFU PR8, PR8-GP~33~, or PR8--2W as noted in each figure legend. This dose of 40 PFU represents a commonly utilized infection dose that in our model leads to weight loss and development of clinical respiratory illness, but where all animals go on to recover from infection^[@R30],\ [@R31]^. For heterologous re-challenge studies, Mice were mock-infected or challenged with 40 PFU PR8 or X31. 45 days following initial infection, animals were challenged with 2000 PFU PR8. Mice were anesthetized using ketamine/xylazine and administered virus diluted in 50ul PBS or 50ul PBS along for mock infections via intranasal administration^[@R49]^.

Virus titers {#S14}
------------

At designated times after infection, mice were euthanized, perfused with PBS, and lungs were harvested in 1mL PBS + 0.5% BSA in Precellys tubes. Tissues were homogenized using a Precellys homogenizer. Samples were then centrifuged and supernatants were aliquoted and snap frozen. Pulmonary virus titers were determined on frozen lung aliquots by plaque assay as previously described^[@R49]^.

Preparation of samples for Flow Cytometry and Acquisition of Samples {#S15}
--------------------------------------------------------------------

At the designated times after infection, mice were euthanized, and tissues were perfused with PBS by cardiac injection. Lungs and/or dLN were harvested and single cell suspensions were created by enzymatic digestion with type IV collagenase (Fisher/Worthington) and DNase I (Sigma) and GentleMacs (Miltemyi) processing.

For flow cytometry staining, single cell homogenates were blocked in 2% rat serum for 10 min at room temperature, incubated with specified antibodies for 30 min on ice, fixed with BD FACS Lysis buffer for 10 min at room temperature, resuspended in PBS, and run on the LSRII (BD). Samples were analyzed using FlowJo software (BD).

The following anti-mouse antibodies conjugated to fluorochromes were utilized for flow cytometry: (company, clone) α-CD3ε (eBioscience/Invitrogen, 145--2C11), α-CD4 (Biolegend, GK1.5), α-CD8α (Biolegend, 53--6.7), α-CD11b (eBioscience/Invitrogen, M1/70), α-CD11c (eBioscience/Invitrogen, N418), α-CD19 (eBioscience/Invitrogen, 1D3), α-CD40 (Biolegend, HM40--3), α-CD44 (BD, IM7), α-CD45.1 (eBioscience/Invitrogen, A20), α-CD45.2 (Biolegend, 104), α-CD69 (Biolegend, H1.2F3), α-CD103 (Biolegend, 2E7), α-F4/80 (eBioscience/Invitrogen, BM8), α-IFNAR1 (Biolegend, MAR1--5A3), α-IFNγ (eBioscience/Invitrogen, XMG1.2), α-MHCII (eBioscience/Invitrogen, M5/114.15.2), α-TNFα (eBioscience/Invitrogen, MP6-XT22).

Analysis of T cell responses {#S16}
----------------------------

WT, *Ifnlr1*^*--/--*^, *Ifnlr1*^*fl/fl*^, *Ifnlr1*^*fl/fl*^*Itgax*-cre, or *Ifnlr1*^*fl/fl*^*Lyz2*-cre mice were infected i.n. with 40 PFU PR8 or PR8 containing the 2W1S epitope or administered an equivalent volume of PBS. Lung single cell homegnates from day 9 post infection were stained with NP~366~ MHCI tetramer, the PA~224~ MHCI tetramer, the NP~311~ MHCII tetramer, the 2W1S MHCII tetramer, or the control CLIP MHC II tetramer (NIH Tetramer Core) to enumerate IAV-specific CD4^+^ and CD8^+^ T cells from lung homogenates harvested on day 9 and 35 (WT and *Ifnlr1*^*--/--*^ only) post infection. For MHCII tetramer staining, CD4^+^ T cell frequencies shown in graphs are for NP311 or 2W1S minus the CLIP negative control. For WT and *Ifnlr1*^--/--^ infection experiments harvested on day 9, a portion of the cells were stimulated with NP~366~, PA~224~, NP~311~ peptides (Genemed Synthesis, Inc), PMA + Ionomycin (Sigma), or incubated with media only for 6 hours in the presence of brefeldin A (Sigma). Following incubation, cytokine production was determined by staining for flow cytometry.

in vivo T cell activation and proliferation {#S17}
-------------------------------------------

For *in vivo* T cell activation and proliferation experiments, 1×10^6^ CFSE-labeled P14 T cells specific for the GP~33~ epitope on the CD45.1 background were adoptively transferred i.v. to WT or *Ifnlr1*^*--/--*^ mice. Approximately 24 hours later, mice were infected i.n. with 40 PFU PR8 containing the GP~33~ epitope or administered an equivalent volume of PBS. Lung-draining lymph nodes were harvest 92 hrs post infection. Single cell suspensions of tissues were created and surface staining for flow cytometry was performed.

BMDC Generation, virus infection, sample harvest and DQ-OVA {#S18}
-----------------------------------------------------------

BMDCs were generated from WT and *Ifnlr1*^--/--^ bone marrow as previously described^[@R53]^. Briefly, bone marrow cells from WT and *Ifnlr1*^*--/--*^ mice were isolated and cultured for 7 days in complete RPMI-1640 (Gibco) containing 20 ng/mLGM-CSF (Peprotech) and 20 ng/mL IL-4 (Peprotech). BMDCs were infected at an MOI 0.5 with PR8 in PBS containing Ca/Mg and 0.5% BSA for 1hr at 37° rocking. Following infection, BMDCs were incubated in complete RPMI until harvest. For qRT-PCR analysis, samples were harvested in RLT buffer, and RNA was isolated using an RNeasy Extraction Kit (Qiagen). cDNA was sythensized (BioRad iScript Kit), and relative gene expression was determined by qRT-PCR on a VIIA7 (Life Technologies) using the TaqMan Fast Advanced Master Mix (ThermoFisher) and primers specific for murine *Ifnlr1* (Thermofisher Mm00558035_m1), murine *Ifnar1* (Thermofisher Mm00439544_m1), murine *Il10rb* (ThermoFisher Mm00434157_m1), murine *Gapdh* (ThermoFisher Mm99999915_g1), and IAV NP (IDT). For IL-10 cytokine analysis supernatants were harvested and subsequent IL-10 levels were determined by multiplex immunoassay (Affymetrix Procartaplex).

For western blot analysis, BMDCs were stimulated with 500ng/mL recombinant murine IFN-λ3 (R&D) or 10ng/mL recombinant murine IFNα2 (R&D) for 1 hr, or 0.1, 1, 10, or 100ng/mL recombinant murine IFN-λ3 (R&D) for 30 min. Following stimulation, cell pellets were collected in RIPA buffer (ThermoFisher) with 1x HALT Protease/Phosphatase inhibitor added (ThermoFisher). Samples were run on an SDS-Page gel, transferred to PVDF, and probed for phospho-STAT1 at site Y701 (Cell Signaling, 58D6), total STAT1 (Cell Signaling, \#9172), and Actin (Cell Signaling, D6A8). For phospho- and total STAT1 α-rabbit HRP (Jackson ImmunoResearch) and SuperSignal West Femto Maximum Sensitivity Substrate (ThermoFisher) were used and chemiluminescent signal detected on X-Ray film. For Actin, α-rabbit AF680 (Jackson ImmunoResearch) or α-rabbit HRP (Jackson ImmunoResearch) was used to detect fluorescent signal on a LI-Cor Odyssey or chemiluminescent signal using a ChemiDoc XRS+ (BioRad).

To determine ISG gene induction by BMDCs following stimulation, WT BMDCs were stimulated with 500ng/mL recombinant murine IFN-λ3 (R&D) for 12 hrs. Following stimulation samples were harvested in RLT buffer, and RNA was isolated using an RNeasy Extraction Kit (Qiagen). cDNA was sythensized (BioRad iScript Kit), and relative gene expression was determined by qRT-PCR on a VIIA7 (Life Technologies) using the SYBR Green Master Mix (ThermoFisher) and the following murine-specific primers (IDT): mChmp2a Fwd (5'-AGACGCCAGAGGAACTACTTC-3'), mChmp2a Rev (5'-ACCAGGTCTTTTGCCATGATTC-3'), mIfi44 Fwd (5'-GTAACACAGCAATGCCTCTTGT-3'), mIfi44 Rev (5'-AACTGACTGCTCGCAATAATGT-3'), mIfit1 Fwd (5'-CTGAGATGTCACTTCACATGGAA-3'), mIfit1 Rev (5'-GTGCATCCCCAATGGGTTCT-3'), mIsg15 Fwd (5'-GGTGTCCGTGACTAACTCCAT-3'), mIsg15 Rev (5'-TGGAAAGGGTAAGACCGTCCT-3'), mOas3 Fwd (5'-TCTGGGGTCGCTAAACATCAC-3'), and mOas3 Rev(5'-GGCAATCCTTATCACTCTTGGTC-3').

For antigen uptake/processing assay, BMDCs were incubated with 10 μg/mL DQ-OVA (ThermoFisher) in PBS for 30 min, 1 hr, or 2 hr at 37° or 2 hr on ice as a control as previously described^[@R54]^. For flow cytometric analysis, samples were harvest at designated times post infection or DQ-OVA administration and stained as described above.

Lung CFSE labeling for DC migration {#S19}
-----------------------------------

Mice were anesthetized using ketamine/xylazine and administered 8 mM CFSE (ThermoFisher) intranasally as previously described^[@R55]^. Shortly after CFSE administration mice were infected with PR8. 24hrs post infection, lungs and dLN were harvested and prepared for analysis by flow cytometry as described above.

Isolation of iDC and CD103^+^ DCs for gene expression analysis {#S20}
--------------------------------------------------------------

iDCs and CD103^+^ DCs were sorted from naive lungs of WT mice using a FACS Aria with the gating strategy shown in [Figure 5](#F5){ref-type="fig"}. RNA was harvested from these cells and cDNA was amplified utilizing the Cells-to-ct kit (ThermoFisher) according to manufacturers instructions. *Ifnar1* and *Ifnlr* message was determined by RT-qPCR as described above.

mRNA sequencing {#S21}
---------------

On day 4 following IAV infection, dLN were isolated from WT and *Ifnlr1*^*--/--*^ mice. Single cell suspensions were prepared as described above. DC were enriched using a StemCell DC enrichment kit separation (StemCell), and cDC were sorted into RLT buffer using a FACS Aria with the gating strategy shown in [Figure 5](#F5){ref-type="fig"}. RNA was isolated (Qiagen RNeasy Micro Kit) and quality of RNA was assessed using an RNA 6000 Pico Kit run on a Bioanalyzer (Agilent). cDNA was amplified (Takara SMART-Seq v4 Ultra Low Input RNA Kit), purified (Zymo DNA Clean and Concentrator), and analyzed (Qubit). Samples were tagmented and amplified (Nextera XT DNA Library Prep Kit). The samples were then cleaned using AMPure XP beads and the quality of final samples was determined using the Bioanalyzer DNA High Sensitivity Kit (Agilent) before sequencing on an Illumina MySeq. All kits for sample preparation were used according to manufacturers protocols.

RNAseq Data Processing and Analysis {#S22}
-----------------------------------

Raw RNAseq data (Fastq files) were demultiplexed and checked for quality using FastQC (0.11.3). Next rRNA was digitally removed using Bowtie2 (2.3.4). Sufficient host reads (\~twenty million) were then mapped to the Mouse genome (MM10) using STAR (2.5.3a) and converted into gene counts with ht-seq (0.6.1). Both the genome sequence (fasta) and gene transfer files (gtf) for mouse were obtained using Illumina's igenomes website (<https://support.illumina.com/sequencing/sequencing_software/igenome.html>). Gene counts were then loaded in the R statistical programming language (3.4.3) and filtered by a row sum of fifty or more across all samples. Exploratory analysis and statistics were also run using R and bioconductor (3.4). The gene count matrix was normalized using voom through the limma bioconductor package (3.34.8). Statistical analysis (including differential expression) was performed using the limma package^[@R56]^. A Venn diagram was created using the Venn counts function through the limma bioconductor package in R. Scatterplot was generated in Spotfire (7.11.1) using log2 fold changes values where genes were deemed statistically significant in at least one of the two comparisons (WT vs. Mock and *Ifnlr1*^*--/--*^ vs. Mock) and displayed. To produce co-expression heat maps, we performed co-expression analysis on genes statistically significant in the DE analysis (threshold: log2 fold change ≥ \| 1.5 \| and false discovery rate (FDR) ≤ 0.05) in at least one comparison (WT and *Ifnlr1*^*--/--*^) against their mock control. The union of these DE genes were loaded into R. Correlations (ward.2 clustering and euclidean distance) were run on the union of log2FC using the WGCNA (1.61) and gplots (3.0.1) bioconductor packages in R^[@R56],\ [@R57]^. To produce the *Il10* gene network, we first identified a cell mediated immunological network containing *Il10* using Ingenuity Pathway Analysis (IPA). The network was derived from known connections in the Ingenuity knowledge base, which include published gene-to-gene correlations, knockout studies, and protein-protein interactions. The network was overlayed using log2 fold change expression values from WT and *Ifnlr1*^*--/--*^ and then exported into cytoscape (3.2.1) for visualization. This data set is available on GEO under accession GSE124399, and the markdown of our analysis of this data is available at <https://hemann.galelab.org/>.

Statistics {#S23}
----------

Statistics were calculated using GraphPad Prism 7.0. Specific statistical analyses used are described in legend for each figure and include log-rank test, one-way analysis of variance (ANOVA) with Tukey's multiple comparisons test, and unpaired two-sided t-test.

Data Availability Statement {#S24}
===========================

The data that support the findings of this study are available from the corresponding author upon reasonable request. The RNAseq data set is available on GEO under accession GSE124399, and the markdown of our analysis of this data is available at <https://hemann.galelab.org/>.
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![IFN-λ signaling is critical for protection against heterologous IAV challenge.\
**a. wildtype (**WT) (solid lines) and *Ifnlr1*^--/--^ (dashed lines) mice were mock treated (green lines) or infected intranasally (i.n.) with 40 PFU PR8 (blue lines) or X31 (a mouse adapted H3N2 strain containing HA and NA from A/HK/3/68 and all other gene segments from PR8, red lines). 45 days post infection (p.i.), mice were challenged i.n. with high dose (2000 PFU) PR8. Following high dose challenge, weight (**a**), illness (**b**), and survival (**c**) were monitored for 14 days. Dashed line in **b** indicates presence of respiratory illness. For **a-c** data from two pooled experiments shown. Error bars show mean ± SEM. For Mock-Mock n=2 mice/group, Mock-PR8 n=8 (WT) or 9 (*Ifnlr1*^*--/--*^) mice/group, PR8-PR8 n=4 (WT) or 9 (*Ifnlr1*^*--/--*^) mice/group, X31-PR8 n=21 (*Ifnlr1*^--/--^) or 22 (WT) mice/group. Significance comparing WT X31-PR8 to WT PR8-PR8 and *Ifnlr1*^*--/--*^ X31-PR8 to WT X31-PR8 was determined using log-rank test. n.s. indicates p=0.3720, \* indicates p\<0.01](nihms-1528211-f0001){#F1}

![IFN-λ signaling is critical for memory T cell responses.\
WT and *Ifnlr1*^--/--^ mice were mock- or IAV-infected i.n. with PBS or 40 PFU PR8. On day 35 p.i., lung-draining lymph nodes (dLN) were harvested and IAV NP~366~-specific CD8^+^ T cell (**a**) and NP~311~-specific CD4^+^ T cell (**b**) frequency (% of CD8^+^ or CD4^+^ T cells) and numbers were determined by flow cytometry. Data from two, pooled experiments shown. For (**a**) 4 (Mock) and 12 (WT and *Ifnlr1*^*--/--*^ D35 p.i.) mice/group with half as many data points shown as each point shows pooled dLN from two mice. For (**b**) 4 (Mock), 14 (WT D35 p.i.), or 10 (*Ifnlr1*^*--/--*^ D35 p.i.) mice/group with half as many data points shown as each point shows pooled dLN from two mice. For (**a**) and (**b**) error bars represent mean ± SEM. Significance was determined using one-way ANOVA followed by Tukey's multiple comparisons test between WT D35 and *Ifnlr1*^*--/--*^ D35. \* indicates p\<0.05, \*\* indicates p\<0.001](nihms-1528211-f0002){#F2}

![IFN-λ signaling is required for viral control and generation of the CD8^+^ T cell response during IAV infection.\
**a-d**. WT and *Ifnlr1*^--/--^ mice were mock- or IAV-infected i.n. with PBS or 40 PFU PR8 expressing a 2W epitope, respectively. **a**. Lungs were harvested on day 9 p.i. and frequency (% of CD8^+^ T cells) and numbers IAV-specific CD8^+^ T cells were determined by flow cytometry. **b-d**. On day 9 p.i., whole lung homogenates were stimulated with media, IAV (NP~366~) peptide, or PMA + ionomycin for 6 hrs in the presence of brefeldin A. Following stimulation, IFN-γ **(b)** and TNF **(c)** single- or co-production **(d)** was determined by flow cytometry. For **a**-**b**, two pooled independent experiments are shown. For (**a**) n=2 (*Ifnlr1*^*--/--*^ Mock), 3 (WT Mock), 5 (WT-IAV), or 7 (*Ifnlr1*^--/--^-IAV) mice/group. For (**b**) n=6 (WT-IAV), or 8 (*Ifnlr1*^--/--^-IAV) mice/group. For **a-d** error bars represent mean ± SEM. Significance was determined using one-way ANOVA followed by Tukey's multiple comparisons test between WT-IAV and *Ifnlr1*^--/--^-IAV.](nihms-1528211-f0003){#F3}

![DCs, but not CD8^+^ T cells, lacking *Ifnlr1* have intrinsic defects.\
**a**. WT and *Ifnlr1*^--/--^ splenic CD8^+^ T cells were CFSE-labeled, stimulated for 72 hrs with α-CD3/CD28, and cell division and CD44 and CD69 upregulation were determined. Data representative of two independent experiments. **b**. 10^6^ CFSE-labeled, P14 transgenic CD8^+^ T cells were transferred to WT and *Ifnlr1*^--/--^ mice and infected i.n. with 40 PFU PR8-GP~33~. dLN were harvested 84 hrs p.i., to determine division of P14 cells. Two pooled independent experiments shown where each data point=dLN pooled from two mice. n=6 (*Ifnlr1*^*--/--*^) or 8 (WT) mice/group. **c-e**. WT and *Ifnlr1*^--/--^ BMDCs were infected with PR8 (MOI=0.5) for 22 hrs. **c**. *Ifnlr1*, *Ifnar1*, and *Il10rb* message was determined by qRT-PCR. Two pooled independent experiments shown. n= 3 (Mock) or 4 (PR8). **d**. CD40 expression was determined by flow cytometry. Three pooled independent experiments shown. n=3 (WT) or 4 (*Ifnlr1*^--/--^) **b-d**. Bars show mean ± SEM. **e**. IAV NP message was determined by qRT-PCR. Two pooled independent experiments shown. Bars show mean ± SEM. n=2 (Mock), 4 (IAV) **f**. WT and *Ifnlr1*^--/--^ BMDCs were incubated with 10 ug/ml DQ-Ova for 30 min, 1 hr, or 2 hr at 37° C or 2 hr on ice, and uptake of DQ-Ova was measured using flow cytometry. One representative of three independent experiments shown where n=3. Mean ± SD shown. For **b**, **d**, and **f** statistical significance determined using an unpaired two-sided t-test comparing WT and *Ifnlr1*^*--/--*^. For **c** significance determined using one-way ANOVA and Tukey's multiple comparisons test. \* indicates p\<0.05, \*\* indicates p\<0.001, \*\*\* indicates p\<0001](nihms-1528211-f0004){#F4}

![IFN-λ signaling is essential for APC migration and accumulation of CD103^+^ DC and CD8α+ DC subsets in dLN during IAV infection.\
**a-c**. WT and *Ifnlr1*^--/--^ mice were administered CFSE i.n. and infected with 40 PFU PR8 i.n.. 24 hrs post infection, lungs and dLN were harvested. **a**. CFSE labeling of the lung as determined by flow cytometry. **b**. CFSE^+^/CD11c^+^ cells (upper right quadrant) in dLN determined by flow cytometry. **c**. Quantification of the frequency of CFSE^+^/CD11c^+^ cells in dLN. **a-c**. Data from two pooled independent experiments shown. n=4 mice/group **d-g**. WT and *Ifnlr1*^--/--^ mice were infected with 40 PFU PR8 i.n., and 72 hrs post infection dLN were harvested. The frequency and total number of the following DC populations in dLN was determined by flow cytometry utilizing the gating strategy in **d**. **e**. iDCs (CD3^−^/CD19^−^/F480^−^/CD11b^+^/CD11c^+^/MHCII^+^), cDCs (CD3^−^/CD19^−^/F480^−^/CD11b^−^/CD11c^+^/MHCII^+^), **f**. CD4^+^ DCs (CD3^−^/CD19^−^/F480^−^/CD11b^+^/CD11c^+^/MHCII^+^/CD8α^−^/CD4^+^), CD8α^+^ DCs (CD3^−^/CD19^−^/F480^−^/CD11b^+^/CD11c^+^/MHCII^+^/CD4^−^/CD8α^+^), **g**. CD103^+^ DCs (CD3^−^/CD19^−^/F480^−^/CD11b^+^/CD11c^+^/MHCII^+^/CD103^+^). Data pooled from two independent experiments. n=3 (Mock), 9 (WT IAV), or 7 (*Ifnlr1*^*--/--*^ IAV) mice/group. **h**. WT mice were infected with 40 PFU PR8 i.n.. 72 hrs post infection dLN were harvested and the expression of IFNAR on iDCs, CD8α^+^ DCs, and CD103^+^ DCs was determined by flow cytometry. Two pooled independent experiments shown. n=5 mice/group. **a-h**. Bars show mean ± SEM. Significance determined using one-way ANOVA followed by Tukey's multiple comparisons test. **i**. iDCs and CD103^+^ DCs were sorted from naive lungs of WT mice, RNA was isolated and *Ifnar1* and *Ifnlr1* message was determined. Data from two individual mice shown. N.D.=not detected. Bars show mean ± SD. \* indicates p\<0.05, \*\* indicates p\<0.01, \*\*\* indicates p\<0.0001](nihms-1528211-f0005){#F5}

![IFN-λ signaling is essential for APC migration to dLN during IAV infection.\
**a**. WT and *Ifnlr1*^--/--^ mice were infected with 40 PFU PR8 or administered PBS i.n., and dLN were harvested 96 hrs later. DCs were enriched using MACS separation, and cDCs were sorted using gating strategy shown in [Figure 5](#F5){ref-type="fig"}. RNA was isolated, and mRNA was prepared to perform mRNA sequencing. Following data cleanup, significant changes in gene expression for each genotype were determined compared to their respective mock-infected samples using limma package in R (threshold: log2 fold change ≥ 1.5 and FDR ≤ 0.05) and plotted as shown. **b**. Venn diagram of genes up- or down-regulated in cDC during IAV infection compared to mock-infected cDCs for each genotype. **c**. Scatter plots showing genes significantly changed in expression during infection for either genotype compared to their mock. Named genes in dark blue indicated ISGs. *Il10* is highlighted in red. **d**. DC maturation genes significantly up- or down-regulated compared to mock for either genotype were plotted in a heat map. Red=upregulated genes, blue=downregulated genes. **e**. A non-canonical cell-mediated immune network was identified in *Ifnlr1*^*--/--*^ samples and plotted. The same network is shown for WT cDCs. Red=upregulated genes, blue=downregulated genes, white=not significant. **a-e**. n=3 samples from dLN of two mice pooled for each condition. **f**. WT and *Ifnlr1*^*--/--*^ BMDCs were infected with IAV at an MOI of 0.5 for 24hrs. Supernatants were collected and IL-10 levels were determined by Luminex. n=2 biological replicates from individual mice of one experiment representative of two independent experiments. Bars show mean ± SD.](nihms-1528211-f0006){#F6}

![IFN-λ signaling in CD11c^+^ cells is required for generation of the CD8^+^ T cell response during IAV infection.\
*Ifnlr1*^*fl/fl*^ and *Ifnlr1*^*fl/fl*^*Itgax-*cre mice were administered 40 PFU PR8 containing a 2W epitope i.n. and weight loss (**a**) was monitored. Symbols show mean and error bars represent SEM. Lungs were harvested on day 9 post infection and frequency (% of CD8^+^ or CD4^+^ T cells) and numbers of PA~224~-specific CD8^+^ T cells (**b**) and 2W1S-specific CD4^+^ T cells (**c**) were assessed by flow cytometry. For (**b**) and (**c**) two pooled, independent experiments shown. n=9 (*Ifnlr1*^*fl/fl*^*Itgax-*cre) or 10 (*Ifnlr1*^*fl/fl*^) mice/group. Bars show mean ± SEM. Significance was determined using unpaired two-sided t-test. \* indicates p \<0.05, \*\* indicates p\<0.01](nihms-1528211-f0007){#F7}
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